Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)

NCT04400578 is registered in ClinicalTrials.gov with Krankenhaus Barmherzige Schwestern Linz as lead sponsor.

NCT NCT04400578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04400578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)
Lead sponsor
Krankenhaus Barmherzige Schwestern Linz
Phase
Not applicable
Overall status
Completed
Start date
February 7, 2020
Completion date
January 18, 2022
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia grade 1, cervical intraepithelial neoplasia grade 2